The balance of risk and benefit in gene-therapy trials.
Barbour
V
V
D000293:Adolescent; D002986:Clinical Trials as Topic; D015316:Genetic Therapy / Q000009:adverse effects; D006801:Humans; D008297:Male; D020163:Ornithine Carbamoyltransferase Deficiency Disease / Q000628:therapy; D018579:Patient Selection; D014481:United States; D014486:United States Food and Drug Administration